Iritis, glaucoma and corneal decompensation associated with BrightOcular cosmetic iris implant

Ahmad M. Mansour, Iqbal Ike K. Ahmed, Brennan Eadie, Elias Chelala, Joanna S. Saade, Stephen G. Slade, Ali A. Mearza, Dipak Parmar, Marwan Ghabra, Sheila Luk, Alla Kelly, Stephen C. Kaufman

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Purpose: NewColorIris cosmetic iris implants have a record of high ocular morbidity and are no longer in use. Newer generation of iris implants, BrightOcular, have patented posterior grooves in order to decrease iris touch and facilitate aqueous flow around the implant. However, little is known about their safety despite their implantations in 10 countries. Methods: Collaborative case series of patients who had bilateral implantation of cosmetic iris implants solely for cosmetic reasons. Results: 12 cases were collected being distributed as Caucasian (10) and Asian (2), women (11) and man (1) and with a mean age of 32 years. Ocular manifestations were present in 11 subjects and included anterior uveitis (10 of 12; 83.3%), glaucoma (7 of 12; 58.3%) and corneal decompensation (6 of 12; 50%). Visual acuity was normal in seven, decreased in five with two having visual recovery following explantation of the implant. Glaucoma could not be controlled medically in two patients. Conclusions: Cosmetic iris implants carry the risk of ocular damage when implanted in the anterior chamber of normal phakic eyes.

Original languageEnglish (US)
Pages (from-to)1098-1101
Number of pages4
JournalBritish Journal of Ophthalmology
Issue number8
StatePublished - Aug 2016


Dive into the research topics of 'Iritis, glaucoma and corneal decompensation associated with BrightOcular cosmetic iris implant'. Together they form a unique fingerprint.

Cite this